Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Vietnamese exporters need reliability, craftsmanship, customer service mindset to find e-commerce clients: conference 3.